Ardelyx Inc (ARDX) concluded trading on Wednesday at a closing price of $5.58, with 4.03 million shares of worth about $22.49 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -21.74% during that period and on December 04, 2024 the price saw a gain of about 1.45%. Currently the company’s common shares owned by public are about 236.89M shares, out of which, 227.84M shares are available for trading.
Stock saw a price change of 4.30% in past 5 days and over the past one month there was a price change of -5.26%. Year-to-date (YTD), ARDX shares are showing a performance of -10.00% which increased to 12.50% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $4.34 but also hit the highest price of $10.13 during that period. The average intraday trading volume for Ardelyx Inc shares is 3.90 million. The stock is currently trading 6.00% above its 20-day simple moving average (SMA20), while that difference is down -3.22% for SMA50 and it goes to -14.97% lower than SMA200.
Ardelyx Inc (NASDAQ: ARDX) currently have 236.89M outstanding shares and institutions hold larger chunk of about 60.49% of that.
The stock has a current market capitalization of $1.32B and its 3Y-monthly beta is at 0.83. It has posted earnings per share of -$0.31 in the same period. It has Quick Ratio of 3.87 while making debt-to-equity ratio of 0.66. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for ARDX, volatility over the week remained 5.28% while standing at 7.68% over the month.
Stock’s fiscal year EPS is expected to rise by 41.17% while it is estimated to increase by 62.70% in next year. EPS is likely to grow at an annualized rate of 30.00% for next 5-years, compared to annual growth of 28.61% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by H.C. Wainwright on November 11, 2024 offering a Neutral rating for the stock and assigned a target price range of between $11 and $5.50 to it. Coverage by Piper Sandler stated Ardelyx Inc (ARDX) stock as a Neutral in their note to investors on July 02, 2024, suggesting a price target of $7 for the stock. On April 05, 2024, Leerink Partners Initiated their recommendations, while on December 18, 2023, Raymond James Initiated their ratings for the stock with a price target of $12. Stock get a Buy rating from H.C. Wainwright on September 07, 2023.
